SACCO, RODOLFO, COSMA, DAMIANO
 Distribuzione geografica
Continente #
NA - Nord America 1.652
EU - Europa 1.514
AS - Asia 703
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 2
SA - Sud America 1
Totale 3.883
Nazione #
US - Stati Uniti d'America 1.644
IE - Irlanda 514
CN - Cina 393
UA - Ucraina 314
SE - Svezia 309
IT - Italia 106
IN - India 86
FI - Finlandia 77
VN - Vietnam 76
DE - Germania 67
SG - Singapore 66
GB - Regno Unito 64
TR - Turchia 59
FR - Francia 30
BE - Belgio 16
EU - Europa 11
TW - Taiwan 10
CA - Canada 7
RO - Romania 6
RU - Federazione Russa 6
PH - Filippine 4
HK - Hong Kong 2
IR - Iran 2
JP - Giappone 2
KR - Corea 2
AL - Albania 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
GR - Grecia 1
KY - Cayman, isole 1
NL - Olanda 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
Totale 3.883
Città #
Dublin 514
Chandler 323
Jacksonville 220
Nyköping 195
Dearborn 148
Nanjing 114
Wilmington 93
Dong Ket 75
Ann Arbor 65
San Mateo 54
Beijing 53
Princeton 53
Singapore 50
Woodbridge 50
New York 46
Nanchang 38
Ashburn 37
Helsinki 34
Boardman 31
Philadelphia 27
Cedar Knolls 23
Shenyang 23
Tianjin 20
Stevenage 19
Changsha 17
Jiaxing 17
Brussels 16
Hebei 16
Des Moines 13
Kunming 13
Munich 13
Hilden 12
Guangzhou 10
Banqiao 9
Los Angeles 9
Foggia 8
Hangzhou 8
Changchun 6
Kocaeli 6
Milan 6
Ningbo 6
Auburn Hills 5
Borås 5
Leawood 5
Shanghai 5
Toronto 5
Augusta 4
Bari 4
Cluj 4
Fairfield 4
Houston 4
Jinan 4
Pune 4
Seattle 4
Taizhou 4
Zhengzhou 4
Lanzhou 3
Las Vegas 3
Orange 3
Quezon City 3
Rome 3
Shenzhen 3
Trani 3
Buffalo 2
Catania 2
Duncan 2
Genova 2
Hanover 2
Hartlepool 2
Hong Kong 2
Milnthorpe 2
Norwalk 2
Pisa 2
Redwood City 2
Rockville 2
Seoul 2
Southend 2
Washington 2
Auckland 1
Bangkok 1
Barrie 1
Birmingham 1
Blandford Forum 1
Bologna 1
Bothell 1
Bradford 1
Caivano 1
Caserta 1
Chalandri 1
Como 1
Council Bluffs 1
Dalmine 1
Den Haag 1
Dongyang 1
Frankfurt Am Main 1
Frankfurt am Main 1
George Town 1
Hirado 1
Ho Chi Minh City 1
Kolkata 1
Totale 2.628
Nome #
Chemioembolizzazione con particelle embolizzanti a rilascio farmacologico (DEB-TACE) vs tecnica convenzionale (TACE): risposta tumorale e sopravvivenza in pazienti con HCC 216
228 CONVENTIONAL TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (C-TACE) VERSUS DOXORUBICIN ELUTING BEAD (DEB)-TACE FOR HEPATOCELLULAR CARCINOMA: ASSESSMENT OF CLINICAL IMPACT-SHORT AND LONG-TERM PROSPECTIVE STUDY 174
526 Liver stiffness measured by transient elastography. The influence of biochemical activity 112
504 HBV quasispecies selected during lamivudine treatment may contribute to adefovir dipivoxil resistance 112
392 HBeAg defective mutants in active/inactive anti-HBe positive HBV carriers: Possible role of pre-core initiation mutants 111
The tightly regulated inducible expression of the core protein of hepatitis C virus modulates Fas- and TNF alpha-mediated apoptosis in human liver cells 109
[GLUTATHIONE IN THE TREATMENT OF CHRONIC FATTY LIVER DISEASES] 101
Transient elastography improves the management of CHB patients 99
HBeAg defective mutants in active/inactive anti-HBe positive HBsAg carriers: possible role of pre-core initiation mutants 94
Cost effective prediction of sustained response to IFN Alfa-2B or PEG-IFN Alfa 2B plus Ribavirin computing infected cells dynamics by early ALT and HCV-RNA decline 94
Survival after transarterial chemoembolization in early-stage HCC patients excluded from liver transplantation: a prospective cohort study 89
Liver inflammation and acute respiratory distress syndrome in a patient receiving hepatitis B vaccine: a possible relationship? 88
Early prediction of sustained response in chronic hepatitis C patients treated with pegilated IFNs (A-2B or A-2A) plus ribavirin using a bio-mathematical model that describes the dynamics of infected cells 85
Antiapoptotic regulation by hepatitis C virus core protein through up-regulation of inhibitor of caspase-activated DNase. 84
Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma. 82
Hepatitis C virus serotypes in haemodialysis patients in South-East Italy. 81
Liver stiffness measured by transient elastography: The influence of biochemical activity 80
Entecavir for Hepatitis B Virus Flare Treatment in Patients with Crohn’s Disease 80
Selective transcatheter arterial chemoembolization for hepatocellular carcinoma: Evaluation of clinical impact-short and long-term prospective study 77
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment. 77
sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology. 77
Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southeast Italy. 76
The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease. 76
Pulmonary or otolaryngologic extraesophageal manifestations in patients with gastroesophageal reflux disease 76
EARLY AND COST EFFECTIVE PREDICTION OF TREATMENT OUTCOME WITH IFNA2B OR PEG-IFNA2B PLUS RIBAVIRIN COMPUTING INFECTED CELLS DYNAMICS BY ALT AND HCV-RNA DECLINE DURING THE FIRST MONTH 75
MONITORING LIVER STIFFNESS: A NEW TOOL TO MEASURE LIVER FIBROSIS DURING THERAPY 74
Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients. 73
Monitoring liver elasticity: a new tool to measure liver fibrosis during therapy 72
Feasibility and safety of granulocytapheresis in Crohn’s disease: A prospective color study 71
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. 69
Distribution of hepatitis C virus serotypes and duration of infection in HCV infected subjects from a geographical area in Southeast Italy. 69
Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: a cohort study 69
Conventional vs Doxorubicin Eluting Bead Transcatheter Chemoembolization for Hepatocellular Carcinoma. 66
A new model of HBV infection dynamics shows a multiphasic decay of viral load and a short half-life of circulating virus in anti-HBe positive patients treated with lamivudine 64
Endotics system versus colonscopy for the detection of polyps a randomised trial 64
Complete response for advanced liver cancer during sorafenib therapy: case report. 63
Adherence to AASLD guidelines in the real world of HCC in Italy preliminary results of a prospective study 60
Quantitative Determination of Hepatitis C Core Antigen in Therapy Monitoring for Chronic Hepatitis C. 59
Valutazione dell’impatto sulla funzionalità epatica della chemioembolizzazione in pazienti con epatocarcinoma tecnica convenzionale Versus particelle embolizzanti. 57
Efficacy of hemostatic powders in lower gastrointestinal bleeding: Clinical series and literature review 53
Endotics system vs colonoscopy for the detection of polyps 52
Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysis 47
Sustained response to Interferon-ribavirin combination therapy in chronich hepatitis C predicted by a model of viral dynamics using both HCV-RNA and alanine amino transferase. 46
Effectiveness of hemostatic powders in lower gastrointestinal bleeding: a systematic review and meta-analysis 46
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study. 45
Partial Response and Cardiovascular Recovery after Sorafenib Dose Reduction in a Multinodular HCC Patient. 42
Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma 41
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma 33
Stereotactic body radiotherapy vs radiofrequency ablation for the treatment of hepatocellular carcinoma: a meta-analysis 29
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials 24
Utilization of Hepatocellular Carcinoma Surveillance Programs in Patients With Cirrhosis: A Systematic Review and Meta-Analysis 24
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 23
Towards a tailored systemic therapy for liver cancer 22
Target therapies plus somatostatin analogues in NETs: a network meta-analysis 20
Prognostic Role of Post-Induction Fecal Calprotectin Levels in Patients with Inflammatory Bowel Disease Treated with Biological Therapies 19
Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review 18
Reply to Lissing et al. Comment on "Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947" 15
Cholangiocarcinoma in the Era of Immunotherapy 10
Totale 3.964
Categoria #
all - tutte 19.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020399 0 0 0 0 74 84 80 7 62 13 63 16
2020/2021466 48 2 48 1 45 17 52 9 55 100 7 82
2021/2022365 53 4 9 8 54 25 16 21 47 37 7 84
2022/20231.416 116 79 82 112 71 124 6 133 620 10 40 23
2023/2024183 42 14 4 4 16 62 2 5 2 14 1 17
2024/2025124 36 7 12 28 41 0 0 0 0 0 0 0
Totale 3.964